U.S. insulin costs per patient nearly doubled from 2012 to 2016: study
By Robin Respaut and Chad Terhune (Reuters) – The cost of insulin for treating type 1...
Read More
Updated
U.S. top court rejects Helsinn over anti-nausea drug patent in win for Teva
By Andrew Chung WASHINGTON (Reuters) – The U.S. Supreme Court on Tuesday refused to revive Swiss drug company Helsinn Healthcare S.A.’s patent on the lucrative anti-nausea drug Aloxi in a victory for Teva...
Read More
Study in WHO journal likens palm oil lobbying to tobacco and alcohol industries
(The original headline of this Jan. 8 story referred to a “WHO study”. the study was...
Read MoreMany migraine sufferers wary of alcohol as a headache trigger
By Carolyn Crist (Reuters Health) – – Many migraine sufferers avoid alcohol, saying it can trigger the severe headaches, a survey found. Among more than 2,000 migraine patients in the Netherlands, more than a third...
Read More
Chinese scientist who gene-edited babies fired by university
SHENZHEN, China (Reuters) – A Chinese scientist who created what he said were the...
Read MoreShorter waits for new patients at VA than in private sector, U.S. study finds
By Linda Carroll (Reuters Health) – In many cases, veterans get a first appointment at VA hospitals quicker than the general public gets first appointments with health care providers, government researchers report. The...
Read More
AbbVie’s Imbruvica fails to meet main goal in pancreatic cancer study
(Reuters) – AbbVie Inc said on Friday its blockbuster cancer treatment in combination with...
Read More
Samsung Bioepis biosimilar to Roche’s Herceptin wins FDA nod
(Reuters) – The U.S. Food and Drug Administration said on Friday it had approved a...
Read More
Lilly cancer drug fails key trial, will no longer be prescribed
By Ankur Banerjee and Julie Steenhuysen (Reuters) – Eli Lilly and Co said on Friday that its...
Read MoreFDA advisory panel split over Sanofi-Lexicon diabetes drug
By Tamara Mathias and Saumya Joseph (Reuters) – An advisory panel to the U.S. Food and Drug Administration was divided over whether to recommend approval of a treatment for type 1 diabetes developed by Lexicon...
Read More
Scientists reveal ‘ideal diet’ for peoples’ and planet’s health
By Kate Kelland LONDON, Jan 16 (Reuters) – Scientists have unveiled what they say is an...
Read More
Invest in health for global security and growth, Gates urges donors
By Kate Kelland LONDON (Reuters) – Donating billions of dollars to global funds that fight...
Read More
Japan Tobacco ratchets up smokeless war with new products
By Taiga Uranaka TOKYO (Reuters) – Japan Tobacco Inc <2914.T> on Thursday unveiled two...
Read More
Amgen’s postmenopausal osteoporosis drug wins FDA panel backing
By Saumya Joseph and Aakash B (Reuters) – An advisory panel to the U.S. Food and Drug...
Read More
Family behind Purdue Pharma pushed opioid marketing, Massachusetts says
By Nate Raymond BOSTON (Reuters) – Members of the wealthy Sackler family behind Purdue...
Read More
Walgreens and Microsoft partner to develop digital healthcare services
(Reuters) – Drugstore chain Walgreens Boots Alliance Inc and Microsoft Corp said on Tuesday...
Read More
Drug companies greet 2019 with U.S. price hikes
By Michael Erman NEW YORK (Reuters) – Drugmakers kicked off 2019 with price increases in the...
Read More
French court cancels Monsanto weedkiller permit on safety grounds
PARIS (Reuters) – A French court canceled the license for one of Monsanto’s...
Read MoreEdward Lifesciences pays Boston Scientific $180 million to end patent row
By Manas Mishra (Reuters) – Edwards Lifesciences Corp has paid rival Boston Scientific Corp $180 million as part of a settlement to end long-standing patent disputes between the two medical device makers. Boston Scientific...
Read More
China has culled more than 900,000 pigs due to African swine fever
By Dominique Patton and Hallie Gu BEIJING (Reuters) – China has culled 916,000 pigs after...
Read More